Greenbrook TMS Announces Expansion Into Connecticut
TORONTO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Greenbrook TMS Inc. ("Greenbrook" or the "Company") (TSX:GTMS), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States for the treatment of Major Depressive Disorder ("MDD"), is pleased to announce the expansion of its TMS Center network into the State of Connecticut. The Company's subsidiary, Greenbrook TMS Connecticut LLC ("Greenbrook TMS Connecticut"), will begin operating two TMS Centers in Westport and Milford, Connecticut under the clinical leadership of Dr. Serena-Lynn Brown.
Greenbrook expects to partner with other physicians to open additional TMS Centers in Connecticut as part of its regional development strategy.
"We are very pleased to be partnering with Greenbrook as they begin their expansion in the Connecticut region. With this partnership we hope to promote increased awareness, affordability, and quality of care for TMS therapy patients in Connecticut", said Dr. Brown. Dr. Brown will serve as Medical Director of Greenbrook TMS Connecticut.
About Greenbrook TMS Inc.
Operating through 46 Company-operated treatment centers, Greenbrook is a leading provider of TMS, an FDA-cleared, non-invasive therapy for the treatment of MDD, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 160,000 TMS treatments to over 4,500 patients struggling with depression.
Forward-Looking Information
Certain information in this press release, including with respect to the expected opening of additional TMS Centers in Connecticut, constitutes forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events.
Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the "Risk Factors" section of the Prospectus available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
For further information please contact:
Erns Loubser
Chief Financial Officer, Treasurer and Corporate Secretary
Greenbrook TMS Inc.
[email protected]
News published on and distributed by:
